Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:IT

1,486.00 ILs 166.00 12.58%

As of 05:07:20 ET on 01/29/2015.

Company Profile for Pluristem Therapeutics Inc (PSTI)

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Contact Information

Pluristem Therapeutics Inc

Matam Advanced Technology Park
Building 20
Haifa, 31905
Israel
Phone: 972-74-710-7171

Key Executives for Pluristem Therapeutics Inc (PSTI)

Zami AbermanChief Executive OfficerYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil